This pilot study aims to establish that treatment with near infrared light (NIR) reduces cystic macular oedema in patients with a retinal vein occlusion.
These results connect systemic immune modulation with retinal mitochondrial health and inflammatory load—two major contributors to age-related macular degeneration (AMD) progression.
NIR photobiomodulation is protective against bright-light-induced retinal degeneration, even when NIR treatment is applied after exposure to light.
LLLT (PBM) therapy accelerated inflammation resolution and reduced complications in acute iridocyclitis versus standard treatment alone.
Belkin and Schwartz established safety thresholds and therapeutic parameters for ophthalmic low-level laser therapy, informing contemporary protocols.
